tiprankstipranks
Mayne Pharma Group Ltd. (AU:MYX)
:MYX
Australian Market

Mayne Pharma Group (MYX) Income Statement

Compare
27 Followers

Mayne Pharma Group Income Statement

Last quarter (Q4 2024), Mayne Pharma Group's total revenue was AU$200.47M, a decrease of -12.21% from the same quarter last year. In Q4, Mayne Pharma Group's net income was AU$-103.68M. See Mayne Pharma Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
AU$ 388.15MAU$ 183.59MAU$ 157.15MAU$ 400.78MAU$ 456.99M
Gross Profit
AU$ 218.53MAU$ 26.84MAU$ 23.75MAU$ 127.02MAU$ 140.94M
Operating Expenses
AU$ 264.63MAU$ 213.28MAU$ 145.62MAU$ 125.65MAU$ 153.07M
Depreciation and Amortization
AU$ 68.46MAU$ 65.44MAU$ 55.18MAU$ 68.19MAU$ 84.56M
EBITDA
AU$ -116.93MAU$ -193.80MAU$ -78.88MAU$ -182.40MAU$ -34.03M
Operating Income
AU$ -45.86MAU$ -186.44MAU$ -121.88MAU$ 1.36MAU$ -12.13M
Other Income/Expenses
AU$ -144.23MAU$ -81.85MAU$ -9.99MAU$ -265.25MAU$ -115.14M
Pretax Income
AU$ -190.09MAU$ -269.70MAU$ -145.59MAU$ -263.89MAU$ -135.37M
Net Income
AU$ -174.23MAU$ -316.42MAU$ -281.29MAU$ -208.42MAU$ -92.79M
Per Share Metrics
AU$ ―AU$ ―AU$ ―AU$ ―AU$ ―
Basic EPS
AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57AU$ -1.14
Diluted EPS
AU$ -2.19AU$ -3.89AU$ -3.46AU$ -2.57AU$ -1.14
Weighted Average Shares Outstanding
79.62M 81.25M 81.25M 81.25M 81.25M
Weighted Average Shares Outstanding (Diluted)
79.62M 81.25M 81.25M 81.25M 81.25M
Currency in AUD

Mayne Pharma Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis